Elena Miranda

Elena Miranda

Auto-generated profile, based on publicly available information

Elena Miranda

GlaxoSmithKline, Stevenage, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
TKTihana Kasic
Tihana Kasic
PCPiergiuseppe Colombo
Piergiuseppe Colombo
CScristiana soldani
cristiana soldani
CWChiuhui M. Wang
Chiuhui M. Wang
EMElena Miranda
Elena Miranda
AVAntonella Viola
Antonella Viola
Previous studies have suggested that T‐lymphocyte dysfunction might be attributable to nitrative stress induced by reactive nitrogen species (RNS). In this manuscript, we explored this hypothesis and provided a direct demonstration of the inhibitory effects of RNS on human T‐cell signaling, activation, and migration. We found that short exposure of human T cells to RNS induced tyrosine phosphorylation of several proteins, including the CD3ζ chain of the TCR complex, and release of Ca2+from intracellular stores. When the exposure to RNS was prolonged, T cells became refractory to stimulation, downregulated membrane receptors such as CD4, CD8, and chemokine receptors, and lost their ability to migrate in response to chemokines. Since substantial protein nitration, a hallmark of nitrative stress, was observed in various human cancers, intratumoral generation of RNS might represent a relevant mechanism for tumor evasion from immune surveillance.

24 July 2020 in Thorax
Verified
Journal Article
Open access
PDF file
COCatherine Overed-Sayer
Catherine Overed-Sayer
EMElena Miranda
Elena Miranda
RDRebecca Dunmore
Rebecca Dunmore
EMElena Liarte Marin
Elena Liarte Marin
LBLorea Beloki
Lorea Beloki
DCDeborah Clarke
Deborah Clarke
Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease which presents a grave prognosis for diagnosed patients. Nintedanib (a triple tyrosine kinase inhibitor) and pirfenidone (unclear mechanism of action) are the only approved therapies for IPF, but have limited efficacy. The pathogenic mechanisms of this disease are not fully elucidated; however, a role for mast cells (MCs) has been postulated. Objectives The aim of this work was to investigate a role for MCs in IPF and to understand whether nintedanib or pirfenidone could impact MC function. Methods and results MCs were significantly elevated in human IPF lung and negatively correlated with baseline lung function (FVC). Importantly, MCs were positively associated with the number of fibroblast foci, which has been linked to increased mortality. Furthermore, MCs were increased in the region immediately surrounding the fibroblast foci, and co-culture studies confirmed a role for MC–fibroblast crosstalk in fibrosis. Nintedanib but not pirfenidone inhibited recombinant stem cell factor (SCF)–induced MC survival. Further evaluation of nintedanib determined that it also inhibited human fibroblast-mediated MC survival. This was likely via a direct effect on ckit (SCF receptor) since nintedanib blocked SCF-stimulated ckit phosphorylation, as well as downstream effects on MC proliferation and cytokine release. In addition, nintedanib ablated the increase in lung MCs and impacted high tissue density frequency (HDFm) in a rat bleomycin model of lung fibrosis. Conclusion Nintedanib inhibits MC survival and activation and thus provides a novel additional mechanism by which this drug may exert anti-fibrotic effects in patients with IPF.

1 February 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
EMElena Miranda
Elena Miranda
JRJennifer Roberts
Jennifer Roberts
SNSteven Novick
Steven Novick
JLJean-Martin Lapointe
Jean-Martin Lapointe
CBCarla Bruijnzeel-Koomen
Carla Bruijnzeel-Koomen
ISIan Strickland
Ian Strickland

1 June 2022 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
EMElena Miranda
Elena Miranda
HPHayley Pye
Hayley Pye
SBSonia Buckingham
Sonia Buckingham
AAAdriana Alves
Adriana Alves
MRManuel Rodriguez-Justo
Manuel Rodriguez-Justo
Risk assessment represents one of the requirements for all activities involving human tissues within the premises. Although a variety of procedures are available to prepare risk assessments in general, there are no published examples of risks associated with the use of human samples in research. To cover this gap and to give an overview of the evaluation performed in our institution, we summarized the potential risks for the use of human samples in research identified in the projects under the remit of the UCL/UCLH Biobank. The procedures of acquisition, transportation, storage, use, and disposal of human samples, and security of the premises were analyzed. From our experience, there are governance-related risks associated with the process of consenting the patients, with the donor confidentiality, with mislabeling of samples and with the ethical approval associated with the project, and they generally do not compromise the integrity of the samples. On the other hand, samples' integrity is more at risk during collection, storage, transport, and use of the sample. Adequate training and having appropriate standard procedures in place and available for all staff seem to be the most effective control measures to prevent any issue. In addition, appropriate equipment maintenance, contingency plans, and strict regulation and monitoring of the facility security should always be in place. In summary, an appropriate evaluation of the risks associated with the use of human samples in research is one of the requirements for the use of human samples in research and it is fundamental for the protection of staff, students, the institution itself, and the patients. Supporting biobanking, implementing a culture of biosafety in the life sciences, and raising awareness in the scientific and regulatory communities are key ways to anticipate future problems associated with biological and governance risks.

13 September 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
MVMartin Del Castillo Velasco-Herrera
Martin Del Castillo Velasco-Herrera
MYMatthew D Young
Matthew D Young
FBFelipe A Vieira Braga
Felipe A Vieira Braga
ERElizabeth C. Rosser
Elizabeth C. Rosser
EMElena Miranda
Elena Miranda
CBChrysothemis C. Brown
Chrysothemis C. Brown
Inflammation in autoimmune disease is mediated by a complex network of interacting cells. Their identity and cross-talk are encoded in messenger RNA (mRNA). Juvenile idiopathic arthritis (JIA), a chronic autoimmune arthritis of childhood, is characterised by synovial inflammation with infiltration of both innate and adaptive immune cells 1 . Activated T cells play a role in disease 2 but the cell types that drive the recruitment and activation of immune cells within the synovium are not known. Here, we utilised droplet-based and full length single cell mRNA sequencing to obtain a quantitative map of the cellular landscape of JIA. We studied 45,715 cells from the synovial fluid of inflamed knee joints and peripheral blood. We identified a population of synovial innate lymphoid cells (ILCs), shared across patients, that exhibited a unique transcriptional profile in comparison to canonical ILC subtypes. Validation at protein-level across a spectrum of autoimmune arthritides revealed that these ILCs are pathologically expanded in a particular type of JIA. Using statistical tools to assess cellular interactions in synovial fluid, ILCs emerged as a central node of communication, expressing the full repertoire of genes required to orchestrate and maintain the inflammatory milieu. Several ILC-mediated signalling pathways may lend themselves as novel therapeutic targets. Together our findings demonstrate a distinct ILC subtype associated with a tissue-specific childhood autoimmune disease.

2 September 2021 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
LNLydia Neary-Zajiczek
Lydia Neary-Zajiczek
CEClara Essmann
Clara Essmann
ARAnita Rau
Anita Rau
SBSophia Bano
Sophia Bano
NCNeil Clancy
Neil Clancy
DSDanail Stoyanov
Danail Stoyanov
Intraoperative frozen section analysis can be used to improve the accuracy of tumour margin estimation during cancer resection surgery through rapid processing and pathological assessment of excised tissue. Its applicability is limited in some cases due to the additional risks associated with prolonged surgery, largely from the time-consuming staining procedure. Our work uses a measurable property of bulk tissue to bypass the staining process: as tumour cells proliferate, they influence the surrounding extra-cellular matrix, and the resulting change in elastic modulus provides a signature of the underlying pathology. In this work we accurately localise atomic force microscopy measurements of human liver tissue samples and train a generative adversarial network to infer elastic modulus from low-resolution images of unstained tissue sections. Pathology is predicted through unsupervised clustering of parameters characterizing the distributions of inferred values, achieving 89% accuracy for all samples based on the nominal assessment (n = 28), and 95% for samples that have been validated by two independent pathologists through post hoc staining (n = 20). Our results demonstrate that this technique could increase the feasibility of intraoperative frozen section analysis for use during resection surgery and improve patient outcomes.